Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT00408772
Title Oxaliplatin, Capecitabine, and Bevacizumab Followed By Surgery and/or Radiofrequency Ablation in Treating Patients With Colorectal Cancer That Has Spread to the Liver and Cannot Be Removed By Surgery
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of California, Davis
Indications

colorectal adenocarcinoma

Therapies

Bevacizumab + Capecitabine + Oxaliplatin

Age Groups: adult
Covered Countries USA


No variant requirements are available.